Cue Biopharma
CUE
$37.84+10.74%
End of day · as of Sep 17, 2026, 7:15 PM ET
Mkt cap
$59.48M
EV/Sales
1.18
P/E ratio
N/A
FY2025 Revenue
$27.47M
EPS (H1 2026)
$-28.39
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-96.85%
Beta
1.42
Div yield
N/A
Sector
Healthcare
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported CUE revenue for 2025-12-31 was $27.5M. Net income was -$26.6M. Revenue was up 195.7% from 2024-12-31 to 2025-12-31. CUE currently screens at market cap $59.5M.
Use this CUE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CUE income, balance, and cash tables.
Cue Biopharma (CUE) is a biotechnology company in the Healthcare sector.
Latest cached Cue Biopharma (CUE) revenue for Dec 31, 2025 was $27.5M. Net income was -$26.6M. Statements: https://lician.com/financials/cue
Cue Biopharma (CUE) market capitalization is $59.5M on the latest cached snapshot.
Cue Biopharma (CUE) cached previous close $34.17; day range $34.20 – $38.07; volume 194,698. Session quote: https://lician.com/quote/cue
Cue Biopharma (CUE) latest cached earnings event is "CUE earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CUE filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/cue